63 Healthcare Investment companies

Rubicon is an entrepreneurial healthcare investment firm focused on building and growing transformational companies.

NLC - the European Healthtech Venture Builder - is dedicated to advancing health, making it accessible for everyone.

We are an early-stage growth equity firm funding big ideas in healthcare and enterprise technology.

FORM is a venture capital firm investing in transformative tech-enabled health, wellness, and longevity companies in the US and Europe to keep people healthy.

We invest in need-driven founders building health tech companies with international ambitions.

We seek to invest in health care solutions for communities that have been long ignored.

We are open-ended (not limited by timeframe), no need to exit under the pressure of time like standard VCs.

We’re more than just investors. We’re an alliance of passionate people on a mission to advance women’s reproductive health.

Building next generation companies to enhance healthy lifespan.

K2 HealthVentures provides venture debt and equity capital to private and public life science & healthcare companies.

We identify, invest and nurture biotech companies that make a difference in healthcare.

Accelerating the future of healthcare.

Santé invests at the leading edge of innovation in healthcare and technology. We manage approximately one billion dollars of capital in two separate strategies.

Arboretum Ventures is an early-stage venture capital firm that invests in high potential private healthcare and life sciences companies.

We build and invest in companies that transform healthcare.

A venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in…

We actively support entrepreneurs' new and brilliant ideas to allow them to grow into competitive businesses.

Investing globally at the convergence of life sciences, healthcare & tech.

Igniting the path to sustainable and affordable innovation.

Investing in disruptive, early-stage biopharma companies across Europe.